Walleye Capital’s Sarepta Therapeutics SRPT Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $7.46M | Buy |
436,225
+423,278
| +3,269% | +$7.24M | 0.03% | 311 |
|
|
2025
Q1 | $826K | Buy |
12,947
+8,515
| +192% | +$543K | ﹤0.01% | 901 |
|
|
2024
Q4 | $539K | Sell |
4,432
-5,453
| -55% | -$663K | ﹤0.01% | 1135 |
|
|
2024
Q3 | $1.23M | Sell |
9,885
-25,777
| -72% | -$3.22M | ﹤0.01% | 949 |
|
|
2024
Q2 | $5.63M | Sell |
35,662
-4,317
| -11% | -$682K | 0.01% | 438 |
|
|
2024
Q1 | $5.18M | Sell |
39,979
-68,862
| -63% | -$8.91M | 0.01% | 430 |
|
|
2023
Q4 | $10.5M | Buy |
108,841
+67,073
| +161% | +$6.47M | 0.02% | 188 |
|
|
2023
Q3 | $5.06M | Buy |
41,768
+31,032
| +289% | +$3.76M | 0.01% | 388 |
|
|
2023
Q2 | $1.23M | Sell |
10,736
-9,593
| -47% | -$1.1M | ﹤0.01% | 679 |
|
|
2023
Q1 | $2.8M | Sell |
20,329
-27,340
| -57% | -$3.77M | 0.04% | 430 |
|
|
2022
Q4 | $6.18M | Buy |
+47,669
| New | +$6.18M | 0.11% | 217 |
|
|
2022
Q3 | – | Hold |
0
| – | – | – | 2716 |
|
|
2022
Q2 | – | Sell |
-53,361
| Closed | -$4.17M | – | 2649 |
|
|
2022
Q1 | $4.17M | Buy |
53,361
+31,488
| +144% | +$2.46M | 0.11% | 182 |
|
|
2021
Q4 | $1.97M | Buy |
21,873
+17,626
| +415% | +$1.59M | 0.06% | 320 |
|
|
2021
Q3 | $393 | Buy |
+4,247
| New | +$393 | 0.01% | 872 |
|
|
2021
Q2 | – | Sell |
-11,282
| Closed | -$841 | – | 1488 |
|
|
2021
Q1 | $841 | Buy |
+11,282
| New | +$841 | 0.05% | 357 |
|
|
2020
Q1 | – | Hold |
0
| – | – | – | 904 |
|
|
2019
Q4 | – | Hold |
0
| – | – | – | 1034 |
|
|
2019
Q3 | – | Sell |
-11,111
| Closed | -$1.69M | – | 945 |
|
|
2019
Q2 | $1.69M | Buy |
+11,111
| New | +$1.69M | 0.19% | 4 |
|